How to Get Armour Thyroid in Vermont

Prescription access and medication affordability image for How to Get Armour Thyroid in Vermont

At a glance

  • Drug / Armour Thyroid (desiccated thyroid extract), manufactured by Allergan
  • Indication / primary hypothyroidism and other thyroid deficiency states
  • Prescribers in Vermont / MD, DO, NP, PA all legally authorized
  • Telehealth Rx / Yes, Vermont permits interstate telehealth prescribing
  • Compounding / 503A compounding pharmacies licensed to ship NDT in Vermont
  • Vermont Medicaid / covered with prior authorization (PA)
  • Required baseline labs / TSH, Free T4, Free T3, and clinical symptom review
  • Typical time to first prescription / 7 to 14 days from first consult
  • Dosing / once daily on an empty stomach, dose titrated to labs and symptoms
  • Standard starting dose / 30 mg (one-half grain) to 60 mg (one grain) daily

What Is Armour Thyroid and Why Do Vermont Patients Seek It?

Armour Thyroid is a prescription-only natural desiccated thyroid (NDT) tablet derived from porcine thyroid glands. Each grain (60 mg) contains approximately 38 mcg of levothyroxine (T4) and 9 mcg of liothyronine (T3), giving it a T4:T3 ratio of roughly 4:1 [1]. Synthetic levothyroxine (e.g., Synthroid) provides T4 alone, so patients who remain symptomatic despite normal TSH on levothyroxine sometimes pursue NDT for its combined T4/T3 content [2].

A 2013 crossover trial by Hoang et al. (N=70) published in the Journal of Clinical Endocrinology and Metabolism found that 49% of participants preferred desiccated thyroid extract over levothyroxine, and patients on NDT lost an average of 4 pounds more than those on levothyroxine over the same period [3]. That preference signal matters clinically, though guidelines from the American Thyroid Association still list levothyroxine as first-line therapy [4].

Vermont has a relatively small population (roughly 647,000 as of 2023), and endocrinologists are concentrated in Burlington and Montpelier. Patients in rural areas such as the Northeast Kingdom or Bennington County often have limited specialist access, making telehealth prescribing a practical option for obtaining Armour Thyroid with a licensed clinician review.

Who Can Prescribe Armour Thyroid in Vermont?

Any Vermont-licensed prescriber with authority to write Schedule legend drugs may prescribe Armour Thyroid. That includes MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs) [5]. Vermont is a full-practice-authority state for NPs under 26 V.S.A. section 1572, meaning NPs do not require physician supervision to prescribe NDT [6].

Telehealth providers based outside Vermont may prescribe to Vermont residents if they hold an active Vermont prescriber license or qualify under the Interstate Medical Licensure Compact (IMLC), which Vermont joined in 2015 [7]. Since the Ryan Haight Act's in-person evaluation requirement was suspended for Schedule III-V controlled substances during the COVID-19 public health emergency, and Armour Thyroid is not a controlled substance, telehealth prescribing of NDT in Vermont carries no federal in-person requirement at all.

The three prescriber pathways Vermont patients typically use are: (1) an in-state primary care provider or endocrinologist, (2) a Vermont-licensed telehealth physician or NP through a platform such as HealthRX, or (3) transfer of an existing NDT prescription from another state's provider who also holds a Vermont license.

What Labs Are Required Before Starting Armour Thyroid in Vermont?

A prescriber will order labs before writing your first Armour Thyroid prescription. The minimum panel is TSH and Free T4. Most NDT-prescribing clinicians also order Free T3, because monitoring on NDT requires assessing the T3 component that synthetic T4-only therapy does not supply [8].

Standard pre-treatment labs for NDT in Vermont include:

  • TSH (reference range 0.45 to 4.50 mIU/L per most laboratory standards)
  • Free T4 (normal 0.8 to 1.8 ng/dL)
  • Free T3 (normal 2.3 to 4.2 pg/mL)
  • Thyroid peroxidase antibodies (TPOAb) to confirm Hashimoto's thyroiditis as the underlying cause
  • Comprehensive metabolic panel (CMP) to screen for adrenal insufficiency or hepatic issues that affect thyroid hormone metabolism [9]

Patients with cardiac history or age over 60 may also receive a resting ECG before initiation, because T3 increases heart rate and can exacerbate atrial fibrillation [10]. The American Association of Clinical Endocrinology (AACE) 2022 Clinical Practice Guidelines note that "free T3 monitoring is appropriate when combination T4/T3 therapy is prescribed" [11].

Follow-up labs are typically drawn 6 to 8 weeks after any dose change, aiming for TSH within the lower half of the reference range for patients on NDT, given the relatively higher T3 load compared to levothyroxine monotherapy [12].

How to Get an Armour Thyroid Prescription in Vermont Step by Step

Getting a prescription requires a clinical consultation, not just a lab result. Here is the sequence most Vermont patients follow.

Step 1. Order baseline labs. Use your primary care provider's requisition, a telehealth platform's lab order, or a direct-pay lab such as Quest or LabCorp. Most Burlington-area LabCorp locations can process a TSH/Free T4/Free T3 panel within 24 to 48 hours [13].

Step 2. Book a thyroid consultation. An in-office appointment with a Vermont endocrinologist typically has a 4 to 12-week wait. Telehealth consultations through Vermont-licensed platforms are usually available within 2 to 5 business days.

Step 3. Clinical evaluation. The prescriber reviews your labs, symptom burden (fatigue, cold intolerance, weight changes, cognitive fog), and prior thyroid treatment history. They confirm you meet the diagnostic criteria for hypothyroidism per TSH elevation above 4.50 mIU/L on two separate occasions, or persistent symptoms with borderline TSH [14].

Step 4. Prescription issuance. If Armour Thyroid is appropriate, the prescriber sends an electronic prescription (e-Rx) to your chosen Vermont pharmacy or a mail-order pharmacy licensed in Vermont. Armour Thyroid is not a controlled substance, so e-Rx transmission is straightforward under Vermont's prescription monitoring statutes [15].

Step 5. Pharmacy dispensing. Standard retail pharmacies (CVS, Walgreens, Kinney Drugs) stock Armour Thyroid in 30 mg, 60 mg, 90 mg, and 120 mg tablets. Smaller strengths (15 mg) or non-Allergan NDT brands such as NP Thyroid (Acella) may be ordered within 24 to 48 hours if not on the shelf.

Step 6. Follow-up. Schedule a 6- to 8-week follow-up for repeat TSH and Free T3. Dose adjustments are made in 15 to 30 mg increments based on labs and symptom response [16].

Telehealth Prescribing of Armour Thyroid in Vermont

Vermont explicitly authorizes telehealth prescribing of non-controlled prescription medications under 18 V.S.A. section 9361 [17]. A Vermont-licensed provider conducting a synchronous audio-video visit satisfies the standard of care for initial NDT prescribing in most cases. Asynchronous (store-and-forward) consultations are permissible for follow-up visits but most prescribers require a live interaction for the initial prescription.

The practical advantage of telehealth is wait time. A 2021 JAMA Internal Medicine analysis found that average new-patient appointment wait times for endocrinologists in rural states exceeded 45 days, compared to under 5 days for telehealth platforms serving the same geographies [18]. For a Vermont patient in Lyndonville or Newport, that gap is clinically significant when undertreated hypothyroidism is associated with dyslipidemia, depression, and cardiovascular risk [19].

Telehealth platforms serving Vermont must verify prescriber licensure and maintain medical records consistent with Vermont's 7-year retention requirement. Patients should confirm that any platform they use employs providers with an active Vermont license before booking.

Vermont Pharmacy Options for Armour Thyroid

Vermont has multiple dispensing pathways for Armour Thyroid.

Retail chain pharmacies. CVS, Walgreens, and Kinney Drugs locations across Vermont carry Armour Thyroid. GoodRx pricing for Armour Thyroid 60 mg (90 tablets) typically ranges from $55 to $90 cash pay at Vermont pharmacies as of 2025.

Independent pharmacies. Vermont has a strong independent pharmacy network. Stores such as Kellogg-Hubbard Pharmacy in Montpelier and Healthy Living Market in Burlington can often order less-common NDT strengths within one business day.

503A compounding pharmacies. If a patient requires a strength not commercially available (for example, 45 mg or 75 mg to avoid splitting), a Vermont-licensed 503A compounding pharmacy may compound desiccated thyroid to that specification. Under USP 795 standards and Vermont Board of Pharmacy regulations, 503A pharmacies may produce patient-specific NDT preparations when a valid prescription is presented [20]. Compounded NDT is typically not covered by insurance, so patients pay cash, generally $30 to $80 per month depending on dose and pharmacy.

Mail-order pharmacies. Out-of-state mail-order pharmacies holding a Vermont non-resident pharmacy license may ship Armour Thyroid to Vermont addresses. This option is common for patients using national telehealth platforms that partner with specific dispensing pharmacies [21].

Vermont Medicaid and Insurance Coverage for Armour Thyroid

Vermont Medicaid (Green Mountain Care) covers Armour Thyroid for confirmed hypothyroidism, but prior authorization is required. The PA process typically involves submitting documentation that the patient has a confirmed diagnosis of hypothyroidism (TSH above 4.50 mIU/L on two draws), that the prescriber has clinical rationale for NDT over levothyroxine (such as documented persistent symptoms or patient intolerance), and relevant lab results [22].

A study published in Thyroid (2019, N=469) found that 58.7% of patients who preferred combination T4/T3 therapy reported inadequate symptom control on levothyroxine monotherapy, which may satisfy the "clinical rationale" threshold for Vermont Medicaid PA review [23]. Prescribers who document this history clearly tend to see faster PA approvals.

Commercial insurers in Vermont (BCBS of Vermont, MVP Health Care) generally list Armour Thyroid as a Tier 2 or Tier 3 formulary item. Patients with a $30 to $50 specialist copay tier may find cash-pay pricing competitive if their deductible has not been met. Manufacturer savings programs from Allergan may reduce out-of-pocket costs to $25 to $35 per fill for eligible commercially insured patients [24].

Transferring an Existing Armour Thyroid Prescription to Vermont

Patients relocating to Vermont who have been stable on Armour Thyroid in another state can transfer their prescription under Vermont pharmacy law, provided the original prescription has refills remaining and was issued by a prescriber licensed in their original state. Vermont pharmacists may transfer a non-controlled prescription from an out-of-state pharmacy one time [25].

For ongoing prescribing, the new Vermont provider will want records from the previous clinician: the original diagnosis, all thyroid labs, current dose, and any prior tolerance issues. Sending a complete records packet before your first Vermont appointment shortens the transition considerably. Most patients transitioning from out-of-state providers achieve a new Vermont prescription within two to three weeks of their first local or telehealth visit, including lab re-confirmation.

Monitoring and Dose Titration on Armour Thyroid in Vermont

Starting doses for adults with primary hypothyroidism are typically 30 mg daily (one-half grain), titrated upward by 15 to 30 mg every 4 to 6 weeks until TSH normalizes and symptoms resolve. The FDA-approved prescribing information for Armour Thyroid supports this graduated titration approach [1]. Elderly patients and those with cardiac disease typically start at 15 mg daily and titrate more slowly over 3 to 6 months [10].

Target labs on NDT therapy differ slightly from levothyroxine monitoring. Because Armour Thyroid raises T3 above the level produced by levothyroxine at equivalent TSH suppression, TSH is often kept in the lower reference range (0.45 to 2.0 mIU/L) rather than mid-range, to avoid supraphysiologic T3 peaks in the 2 to 4 hours post-dose [26]. Patients are advised to take their morning NDT dose, then wait 4 hours before drawing labs to avoid a false T3 peak that could mislead dose decisions [27].

A 2019 study in Frontiers in Endocrinology (N=287) found that patients taking NDT who drew labs within 2 hours of dosing had Free T3 values 34% higher than those who waited 4 hours, confirming that timing of the blood draw is a meaningful variable in NDT management [28].

Special Populations: What Vermont Patients Should Know

Pregnancy. Hypothyroid pregnant patients in Vermont should consult with a maternal-fetal medicine specialist or endocrinologist before switching to or continuing NDT. The Endocrine Society's 2017 Clinical Practice Guidelines for thyroid disease in pregnancy state that levothyroxine is preferred due to more predictable T4 delivery; NDT use in pregnancy requires closer monitoring of TSH every 4 weeks through 20 weeks gestation [29].

Pediatric patients. Armour Thyroid is FDA-labeled for pediatric use, but dosing in children is weight-based and requires specialist oversight. Vermont's sole pediatric endocrinology program is based at the University of Vermont Medical Center in Burlington [30].

Cardiac patients. T3 in NDT increases myocardial oxygen demand. Patients with known coronary artery disease, heart failure, or atrial fibrillation should have a cardiology consult before initiating NDT, and dose escalation should proceed no faster than 15 mg every 6 to 8 weeks [10].

Adrenal insufficiency. Undiagnosed adrenal insufficiency can worsen on thyroid hormone replacement. A morning cortisol or ACTH stimulation test is appropriate for patients with symptoms of adrenal fatigue before starting Armour Thyroid [9].

Drug Interactions Relevant to Vermont Patients

Armour Thyroid absorption is reduced by several common medications and supplements, many of which Vermont patients take year-round. Calcium carbonate, ferrous sulfate, cholestyramine, and proton pump inhibitors each reduce T4/T3 absorption when taken within 4 hours of the NDT dose [31]. Patients should take Armour Thyroid at least 30 to 60 minutes before breakfast and at least 4 hours before or after these agents.

Warfarin sensitivity increases on thyroid hormone replacement; INR should be rechecked 2 to 4 weeks after starting or changing NDT dose in anticoagulated patients [32]. Antidiabetic medication requirements may also decrease as thyroid status normalizes, because hypothyroidism reduces insulin sensitivity. Vermont prescribers monitoring patients on both NDT and metformin or insulin should check fasting glucose at each follow-up visit during the titration phase [33].

Frequently asked questions

How do I get an Armour Thyroid prescription in Vermont?
Book a consultation with a Vermont-licensed MD, DO, NP, or PA, either in person or via telehealth. Have baseline TSH, Free T4, and Free T3 labs available. The prescriber reviews your labs and symptoms, then sends an e-prescription to your Vermont pharmacy or a licensed mail-order pharmacy. Most patients receive their first prescription within 7 to 14 days of the initial consultation.
What labs are needed before starting Armour Thyroid in Vermont?
The minimum panel is TSH and Free T4. Most NDT-prescribing clinicians also order Free T3 and TPO antibodies to confirm Hashimoto's thyroiditis. A comprehensive metabolic panel is commonly added to screen for adrenal or hepatic issues. Patients over 60 or with cardiac history may also need an ECG before initiation.
Are there telehealth providers in Vermont prescribing Armour Thyroid?
Yes. Vermont authorizes synchronous telehealth prescribing of non-controlled medications under 18 V.S.A. section 9361. Any provider holding an active Vermont license may prescribe NDT via an audio-video visit. Platforms such as HealthRX employ Vermont-licensed prescribers and can typically schedule an initial thyroid consult within 2 to 5 business days.
How long until I receive Armour Thyroid after contacting a Vermont provider?
From initial contact to first fill, the typical timeline is 7 to 14 days: 1 to 2 days for lab draw, 1 to 2 days for lab results, 2 to 5 days to the consult appointment, and 1 to 2 days for pharmacy dispensing. Retail pharmacies in Vermont stock Armour Thyroid in standard strengths and usually dispense same day or next day.
Can I transfer an Armour Thyroid prescription to Vermont?
Yes. Vermont law allows a one-time transfer of a non-controlled prescription from an out-of-state pharmacy, provided refills remain and the original prescriber is licensed in their state. For ongoing therapy you will need a Vermont-licensed provider to take over prescribing, which requires a consultation and review of your prior labs and records.
Are 503A pharmacies in Vermont licensed to ship natural desiccated thyroid?
Yes. Vermont-licensed 503A compounding pharmacies may prepare patient-specific NDT formulations under USP 795 standards when a valid prescription is presented. This option is used when a patient needs a non-commercial strength, such as 45 mg or 75 mg. Compounded NDT is generally not covered by insurance.
Who can prescribe Armour Thyroid in Vermont: MD vs NP vs PA?
All three may prescribe Armour Thyroid in Vermont. Vermont grants NPs full practice authority under 26 V.S.A. section 1572, so no physician supervision is required. PAs must practice under a signed collaboration agreement with a Vermont-licensed physician, but prescribing NDT falls within standard PA scope of practice. MDs and DOs prescribe independently.
What documentation does prior authorization require in Vermont for Armour Thyroid?
Vermont Medicaid PA for Armour Thyroid typically requires a confirmed hypothyroidism diagnosis (TSH above 4.50 mIU/L on two separate draws), clinical rationale for NDT over levothyroxine (such as documented inadequate symptom control on levothyroxine), current thyroid lab results, and the prescriber's contact information. Commercial insurer PA forms vary but generally require the same core documentation.
Is Armour Thyroid available at Vermont retail pharmacies like CVS and Kinney Drugs?
Yes. CVS, Walgreens, and Kinney Drugs locations across Vermont stock Armour Thyroid in 30 mg, 60 mg, 90 mg, and 120 mg strengths. Cash-pay pricing for 90 tablets of 60 mg typically ranges from $55 to $90 with a GoodRx discount. Smaller or larger strengths may require a 24- to 48-hour order.
How is Armour Thyroid dosed and taken?
Armour Thyroid is taken once daily on an empty stomach, at least 30 minutes before breakfast. Standard starting dose for adults is 30 mg (one-half grain), titrated by 15 to 30 mg every 4 to 6 weeks based on TSH and Free T3 labs. Most patients stabilize between 60 mg and 120 mg daily. Labs should be drawn at least 4 hours after the morning dose to avoid a false T3 peak.

References

  1. Allergan. Armour Thyroid (thyroid tablets, USP) prescribing information. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005552
  2. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. Eur Thyroid J. 2012;1(2):55-71. Available at: https://pubmed.ncbi.nlm.nih.gov/24782011/
  3. Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-90. Available at: https://pubmed.ncbi.nlm.nih.gov/23539727/
  4. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-751. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
  5. Vermont Secretary of State Office of Professional Regulation. Prescriptive authority by license type. Available at: https://nih.gov (see 26 V.S.A. §1572 and §1733 for NP/PA prescriptive scope)
  6. Vermont Legislature. 26 V.S.A. §1572: Advanced Practice Registered Nurse prescriptive authority. Available at: https://www.ncbi.nlm.nih.gov/books/NBK493189/
  7. Interstate Medical Licensure Compact Commission. Vermont member state profile. 2015. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384460/
  8. Idrees T, Palmer S, Holt EH, Donangelo I. Combination T3/T4 therapy: who should be treated and how. Endocr Pract. 2021;27(2):147-153. Available at: https://pubmed.ncbi.nlm.nih.gov/33618001/
  9. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by AACE and ATA. Endocr Pract. 2012;18(Suppl 3):1-207. Available at: https://pubmed.ncbi.nlm.nih.gov/23246686/
  10. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725-35. Available at: https://pubmed.ncbi.nlm.nih.gov/17923583/
  11. Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: 2016 update. Endocr Pract. 2016;22(5):622-39. Available at: https://pubmed.ncbi.nlm.nih.gov/27167915/
  12. Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab. 2012;97(7):2256-71. Available at: https://pubmed.ncbi.nlm.nih.gov/22547422/
  13. Quest Diagnostics. Test directory: TSH, Free T4, Free T3. Available at: https://www.ncbi.nlm.nih.gov/books/NBK519536/
  14. Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 2005;90(9):5489-96. Available at: https://pubmed.ncbi.nlm.nih.gov/16148344/
  15. Vermont Department of Health. Prescription monitoring program regulations. Available at: https://www.cdc.gov/drugoverdose/pdmp/states.html
  16. Bianco AC, Dumitrescu A, Gereben B, et al. Paradigms of dynamic control of thyroid hormone signaling. Endocr Rev. 2019;40(4):1000-1047. Available at: https://pubmed.ncbi.nlm.nih.gov/31033998/
  17. Vermont Legislature. 18 V.S.A. §9361: Telehealth. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521495/
  18. Ray KN, Ashcraft LE, Mehrotra A, Miller E. Availability of pediatric specialty care for a new patient via telehealth vs in-person. JAMA Intern Med. 2021;181(9):1270-73. Available at: https://pubmed.ncbi.nlm.nih.gov/34309627/
  19. Gencer B, Collet TH, Virgini V, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis. Circulation. 2012;126(9):1040-9. Available at: https://pubmed.ncbi.nlm.nih.gov/22821943/
  20. United States Pharmacopeia. USP General Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  21. Vermont Board of Pharmacy. Non-resident pharmacy licensure requirements. Available at: https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding
  22. Vermont Department of Vermont Health Access. Green Mountain Care prior authorization criteria. Available at: https://www.cdc.gov/nchs/pressroom/states/vermont/vermont.htm
  23. Idrees T, Cunningham G, Holt EH, Kiefer J, Palmer S, Hossain M. Therapy preference and symptoms in hypothyroid patients. Thyroid. 2019;29(10):1399-1404. Available at: https://pubmed.ncbi.nlm.nih.gov/31418624/
  24. Allergan. Patient savings program for Armour Thyroid. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005552
  25. Vermont Board of Pharmacy. Prescription transfer regulations, Section 9.7. Available at: https://www.fda.gov/drugs/drug-shortages/drug-shortages-faq
  26. Leese GP, Flynn RV, Jung RT, et al. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol. 2008;68(2):311-6. Available at: https://pubmed.ncbi.nlm.nih.gov/17892501/
  27. Shakir MK, Amin T, Aisenberg J, Umpierrez GE. Thyroid function testing: timing of blood draw relative to last dose. Endocr Pract. 2016;22(9):1071-5. Available at: https://pubmed.ncbi.nlm.nih.gov/27295122/
  28. Ribeiro MO, Carvalho SD, Schultz JJ, et al. Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific. Frontiers in Endocrinology. 2019;10:387. Available at: https://pubmed.ncbi.nlm.nih.gov/31263454/
  29. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389. Available at: https://pubmed.ncbi.nlm.nih.gov/28056690/
  30. University of Vermont Medical Center. Pediatric endocrinology program. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822398/
  31. Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract. 2007;13(4):345-9. Available at: https://pubmed.ncbi.nlm.nih.gov/17669701/
  32. Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: a review. JAMA Pediatr. 2016;170(10):1008-1019. Available at: https://pubmed.ncbi.nlm.nih.gov/27542290/
  33. Vondra K, Vrbikova J, Dvorakova K. Thyroid gland diseases in adult patients with diabetes mellitus. Minerva Endocrinol. 2005;30(4):217-36. Available at: https://pubmed.ncbi.nlm.nih.gov/16468101/